Latest Insider Transactions at Annovis Bio, Inc. (ANVS)
This section provides a real-time view of insider transactions for Annovis Bio, Inc. (ANVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Annovis Bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Annovis Bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2023
|
Henry Hagopian Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
824
+31.12%
|
$4,944
$6.07 P/Share
|
|
Nov 20
2023
|
Maria Luisa Maccecchini President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
41,186
+3.61%
|
$247,116
$6.07 P/Share
|
|
Nov 20
2023
|
Mark K. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+3.17%
|
$12,000
$6.07 P/Share
|
|
Nov 20
2023
|
Michael B Hoffman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
164,745
+42.35%
|
$988,470
$6.07 P/Share
|
|
Nov 20
2023
|
Reid Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
824
+9.2%
|
$4,944
$6.07 P/Share
|
|
Nov 20
2023
|
Claudine Bruck Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+11.67%
|
$6,000
$6.07 P/Share
|
|
Apr 24
2023
|
Maria Luisa Maccecchini President and CEO |
SELL
Bona fide gift
|
Direct |
3,000
-0.28%
|
-
|
|
Apr 07
2023
|
Claudine Bruck Director |
BUY
Grant, award, or other acquisition
|
Direct |
500
+7.08%
|
$6,000
$12.61 P/Share
|
|
Apr 07
2023
|
Mark K. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+4.82%
|
$36,000
$12.61 P/Share
|
|
Apr 07
2023
|
Reid Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
476
+6.12%
|
$5,712
$12.61 P/Share
|
|
Apr 07
2023
|
Michael B Hoffman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
59,477
+50.0%
|
$713,724
$12.61 P/Share
|
|
Apr 07
2023
|
Henry Hagopian Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+50.0%
|
$12,000
$12.61 P/Share
|
|
Apr 07
2023
|
Maria Luisa Maccecchini President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+1.85%
|
$240,000
$12.61 P/Share
|
|
Feb 06
2023
|
Maria Luisa Maccecchini President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
52,755
+4.83%
|
$0
$0.14 P/Share
|
|
Jan 14
2022
|
Maria Luisa Maccecchini President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
32,959
+3.23%
|
$0
$0.14 P/Share
|
|
Jan 04
2022
|
Michael B Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,748
-0.24%
|
$128,212
$19.78 P/Share
|
|
Jan 04
2022
|
Michael B Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,142
+1.29%
|
$74,284
$2.32 P/Share
|
|
Oct 12
2021
|
Mark K. White Director |
BUY
Open market or private purchase
|
Direct |
5,000
+8.17%
|
$135,000
$27.4 P/Share
|
|
Oct 11
2021
|
Maria Luisa Maccecchini President and CEO |
BUY
Open market or private purchase
|
Direct |
18,000
+1.81%
|
$486,000
$27.61 P/Share
|
|
Oct 11
2021
|
Claudine Bruck Director |
BUY
Open market or private purchase
|
Direct |
181
+2.9%
|
$4,887
$27.66 P/Share
|
|
Aug 19
2021
|
Reid Mc Carthy Director |
BUY
Open market or private purchase
|
Direct |
500
+6.82%
|
$18,500
$37.61 P/Share
|